Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug
Glenmark Pharmaceuticals, Inc., a subsidiary of Glenmark Pharmaceuticals Ltd. of Mumbai, India, is recalling 1.476 million bottles of a generic Attention Deficit Hyperactivity Disorder (ADHD) medication called atomoxetine from the U.S market, according to the U.S. Food and Drug Administration (FDA).1 Eli Lilly had once marketed the branded version of the drug, Strattera, but stopped […]
Many American Children Chronically Absent from School Are Sick and Disabled
A report released in March 2024 by the U.S. Centers for Disease Control and Prevention (CDC) showed that millions of American children experienced chronic absenteeism from school due to an injury, illness and/or disability.1 Many states define chronic absenteeism as missing 10 percent of school days (or around 18 days) during a school year. The […]
WHO Reports Significant Overuse of Antibiotics to Treat SARS-CoV-2 Infections
The World Health Organization (WHO) presented findings of extensive overuse of antibiotics during the peak years of the COVID-19 pandemic, which may have made the already existing threat of antimicrobial resistance much worse.1 The WHO has called antibiotic resistance one of the greatest global public health threats.2 According to the U.S. Centers for Disease Control […]
One in Four New Jersey Teens With Autism May Be Undiagnosed
A 2023 study published in the Journal of Autism and Developmental Disorders found that despite advances in screening and diagnosis of autism spectrum disorder (ASD), one in 55 teenagers met the criteria for ASD; however, one in four 16-year-olds on the autism spectrum had not received a formal diagnosis.1 Walter Zahorodny, PhD, an associate professor […]
Massachusetts Unprepared to Care for Thousands of Autistic Young Adults
Thousands of autistic children in Massachusetts are reportedly now transitioning into adulthood, and those, who have been diagnosed with severe forms of neurological dysfunction, will experience even more challenges as they get older. Parents, health professionals and child health advocacy groups have warned for years that there will eventually be a growing demand for lifetime […]
Shortage of Adderall Affecting Behavior in Children and Adults
On October 12, 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of a drug formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall. Adderall is an FDA approved drug for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD), including anger, anxiety, forgetfulness and trouble focusing.1 Adderall […]